Male Urogenital Disorders and Metabolic Syndrome: Possible Links, Characteristics and Potential Treatment Strategies

Oztekin C. V., KAYA SEZGİNER E., YILMAZ ORAL D., GÜR S.

CURRENT PHARMACEUTICAL DESIGN, cilt.24, sa.9, ss.1019-1033, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 24 Sayı: 9
  • Basım Tarihi: 2018
  • Doi Numarası: 10.2174/1381612824666171213102836
  • Dergi Adı: CURRENT PHARMACEUTICAL DESIGN
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1019-1033
  • Anahtar Kelimeler: Erectile dysfunction, hypogonadism, infertility, lower urinary tract symptoms, metabolic syndrome, renal diseases, URINARY-TRACT SYMPTOMS, BENIGN PROSTATIC HYPERPLASIA, BODY-MASS INDEX, CHRONIC KIDNEY-DISEASE, C-REACTIVE PROTEIN, ERECTILE DYSFUNCTION PATIENTS, TYPE-2 DIABETES-MELLITUS, CORONARY-HEART-DISEASE, 3RD NATIONAL-HEALTH, SPERM DNA INTEGRITY
  • Ankara Üniversitesi Adresli: Evet

Özet

Background: Metabolic syndrome (MetS), as a cluster of metabolic derangements which are major risk factors for vascular disease is one of the most important threats to public health. Although the epidemiological and limited amount of basic science and clinical evidence link MetS to several male urogenital disorders, a holistic approach aiming to define common mechanistic pathways and new possible therapeutic targets are lacking.